265 related articles for article (PubMed ID: 25867947)
1. Busulfan as a myelosuppressive agent for generating stable high-level bone marrow chimerism in mice.
Peake K; Manning J; Lewis CA; Barr C; Rossi F; Krieger C
J Vis Exp; 2015 Apr; (98):e52553. PubMed ID: 25867947
[TBL] [Abstract][Full Text] [Related]
2. Non-myeloablative busulfan chimeric mouse models are less pro-inflammatory than head-shielded irradiation for studying immune cell interactions in brain tumours.
Youshani AS; Rowlston S; O'Leary C; Forte G; Parker H; Liao A; Telfer B; Williams K; Kamaly-Asl ID; Bigger BW
J Neuroinflammation; 2019 Feb; 16(1):25. PubMed ID: 30722781
[TBL] [Abstract][Full Text] [Related]
3. Perivascular, but not parenchymal, cerebral engraftment of donor cells after non-myeloablative bone marrow transplantation.
Yang Y; Jorstad NL; Shiao C; Cherne MK; Khademi SB; Montine KS; Montine TJ; Keene CD
Exp Mol Pathol; 2013 Aug; 95(1):7-17. PubMed ID: 23567123
[TBL] [Abstract][Full Text] [Related]
4. Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs.
Down JD; Ploemacher RE
Exp Hematol; 1993 Jul; 21(7):913-21. PubMed ID: 8100536
[TBL] [Abstract][Full Text] [Related]
5. Comparison of different busulfan analogues for depletion of hematopoietic stem cells and promotion of donor-type chimerism in murine bone marrow transplant recipients.
Westerhof GR; Ploemacher RE; Boudewijn A; Blokland I; Dillingh JH; McGown AT; Hadfield JA; Dawson MJ; Down JD
Cancer Res; 2000 Oct; 60(19):5470-8. PubMed ID: 11034090
[TBL] [Abstract][Full Text] [Related]
6. Myelosuppressive conditioning using busulfan enables bone marrow cell accumulation in the spinal cord of a mouse model of amyotrophic lateral sclerosis.
Lewis CA; Manning J; Barr C; Peake K; Humphries RK; Rossi F; Krieger C
PLoS One; 2013; 8(4):e60661. PubMed ID: 23593276
[TBL] [Abstract][Full Text] [Related]
7. Busulfan-conditioned bone marrow transplantation results in high-level allogeneic chimerism in mice made tolerant by in utero hematopoietic cell transplantation.
Ashizuka S; Peranteau WH; Hayashi S; Flake AW
Exp Hematol; 2006 Mar; 34(3):359-68. PubMed ID: 16543070
[TBL] [Abstract][Full Text] [Related]
8. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
Li JM; Gorechlad J; Larsen CP; Waller EK
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
[TBL] [Abstract][Full Text] [Related]
9. Submyeloablative conditioning with busulfan permits bone marrow-derived cell accumulation in a murine model of Alzheimer's disease.
Barr CM; Manning J; Lewis CA; Rossi FM; Krieger C
Neurosci Lett; 2015 Feb; 588():196-201. PubMed ID: 25582787
[TBL] [Abstract][Full Text] [Related]
10. Combining Mobilizing Agents with Busulfan to Reduce Chemotherapy-Based Conditioning for Hematopoietic Stem Cell Transplantation.
Garcia-Perez L; van Roon L; Schilham MW; Lankester AC; Pike-Overzet K; Staal FJT
Cells; 2021 Apr; 10(5):. PubMed ID: 33946560
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of polyclonal tregs does not require rapamycin in a low-dose irradiation bone marrow transplantation model.
Pilat N; Klaus C; Gattringer M; Jaeckel E; Wrba F; Golshayan D; Baranyi U; Wekerle T
Transplantation; 2011 Aug; 92(3):280-8. PubMed ID: 21697774
[TBL] [Abstract][Full Text] [Related]
12. Bone Marrow-Derived Cell Accumulation in the Spinal Cord Is Independent of Peripheral Mobilization in a Mouse Model of Amyotrophic Lateral Sclerosis.
Peake K; Manning J; Lewis CA; Tran K; Rossi F; Krieger C
Front Neurol; 2017; 8():75. PubMed ID: 28337172
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow cell recruitment to the brain in the absence of irradiation or parabiosis bias.
Kierdorf K; Katzmarski N; Haas CA; Prinz M
PLoS One; 2013; 8(3):e58544. PubMed ID: 23526995
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow transplantation combined with mesenchymal stem cells induces immune tolerance without cytotoxic conditioning.
Wang Y; Liu J; Xu C; Zhang W; Bai L; Li N; Liu Y; Wang Y; Su Y; Hu D
J Surg Res; 2011 Nov; 171(1):e123-31. PubMed ID: 21920556
[TBL] [Abstract][Full Text] [Related]
15. Cardiac allograft acceptance after localized bone marrow transplantation by isolated limb perfusion in nonmyeloablated recipients.
Askenasy N; Yolcu ES; Shirwan H; Wang Z; Farkas DL
Stem Cells; 2003; 21(2):200-7. PubMed ID: 12634416
[TBL] [Abstract][Full Text] [Related]
16. Flt3-L augments the engraftment of donor-derived bone marrow cells when combined with sublethal irradiation and costimulatory (CD28/B7 and CD40/CD40L) blockade.
Woodward JE; Salam A; Logar AJ; Schaefer AT; Rao AS
Cell Transplant; 2002; 11(2):147-59. PubMed ID: 12099638
[TBL] [Abstract][Full Text] [Related]
17. Towards a myeloablative regimen with clinical potential: I. Treosulfan conditioning and bone marrow transplantation allow induction of donor-specific tolerance for skin grafts across full MHC barriers.
van Pel M; van Breugel DW; Vos W; Ploemacher RE; Boog CJ
Bone Marrow Transplant; 2003 Jul; 32(1):15-22. PubMed ID: 12815473
[TBL] [Abstract][Full Text] [Related]
18. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
[TBL] [Abstract][Full Text] [Related]
19. Myelosuppressive conditioning is required to achieve engraftment of pluripotent stem cells contained in moderate doses of syngeneic bone marrow.
Tomita Y; Sachs DH; Sykes M
Blood; 1994 Feb; 83(4):939-48. PubMed ID: 7906567
[TBL] [Abstract][Full Text] [Related]
20. Low dose busulfan facilitates chimerism and tolerance in a murine model.
Anam K; Black AT; Hale DA
Transpl Immunol; 2006 Jan; 15(3):199-204. PubMed ID: 16431286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
